Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer - PubMed (original) (raw)
Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer
S M Bell et al. Gastroenterology. 1993 Jan.
Abstract
Background: Mutations in Ki-ras codon 12 and the p53 gene are common abnormalities in colorectal cancer. The occurrence of p53 overexpression and/or Ki-ras codon 12 mutations were analyzed in 100 colorectal adenomas to determine if they were related to patient survival.
Methods: p53 overexpression was identified by immunohistochemistry, and Ki-ras codon 12 mutations were detected using the polymerase chain reaction and a restriction enzyme digestion method.
Results: p53 overexpression was identified in 45% of tumors, with a higher frequency identified in DNA aneuploid and left-sided tumors than in DNA diploid and right-sided tumors. Mutations in Ki-ras codon 12 were identified in 24% of carcinomas. Individually, mutations in Ki-ras codon 12 or p53 overexpression were not prognostic indicators of survival. However, a statistically significant difference in survival was identified when these two oncogenic abnormalities were analyzed together. The median survival of patients whose tumors contained both oncogenic abnormalities was less than half of that of patients with either alteration alone or without either abnormality.
Conclusions: Screening for multiple genetic abnormalities in colorectal cancers excised at surgery may prove to be a useful tool in determining prognosis.
Similar articles
- Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
Ahnen DJ, Feigl P, Quan G, Fenoglio-Preiser C, Lovato LC, Bunn PA Jr, Stemmerman G, Wells JD, Macdonald JS, Meyskens FL Jr. Ahnen DJ, et al. Cancer Res. 1998 Mar 15;58(6):1149-58. Cancer Res. 1998. PMID: 9515799 Clinical Trial. - Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.
Rall CJ, Yan YX, Graeme-Cook F, Beauchamp R, Yandell DW, Povoski SP, Rustgi AK. Rall CJ, et al. Pancreas. 1996 Jan;12(1):10-7. doi: 10.1097/00006676-199601000-00002. Pancreas. 1996. PMID: 8927612 - p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H, Gervaz P, Cerottini JP, Benhattar J, Chaubert P, Saraga E, Pampallona S, Bosman FT, Givel JC. Bouzourene H, et al. Eur J Cancer. 2000 May;36(8):1008-15. doi: 10.1016/s0959-8049(00)00036-8. Eur J Cancer. 2000. PMID: 10885605 - Chromosome 12 alterations and c-Ki-ras mutations in colorectal tumors.
Muleris M, Laurent-Puig P, Salmon RJ, Thomas G, Dutrillaux B. Muleris M, et al. Cancer Genet Cytogenet. 1993 Sep;69(2):161-2. doi: 10.1016/0165-4608(93)90097-6. Cancer Genet Cytogenet. 1993. PMID: 8402559 Review. - p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis.
Mulder JW, Wielenga VJ, Pals ST, Offerhaus GJ. Mulder JW, et al. Histochem J. 1997 Jun;29(6):439-52. doi: 10.1023/a:1026403404652. Histochem J. 1997. PMID: 9248852 Review.
Cited by
- Colorectal adenocarcinoma in Uganda: are right-sided and left-sided colon cancers two distinct disease entities?
Wismayer R, Kiwanuka J, Wabinga H, Odida M. Wismayer R, et al. World J Surg Oncol. 2023 Jul 22;21(1):215. doi: 10.1186/s12957-023-03094-7. World J Surg Oncol. 2023. PMID: 37480083 Free PMC article. - Not All Kirsten Rat Sarcoma Viral Oncogene Homolog Mutations Predict Poor Survival in Patients With Unresectable Colorectal Liver Metastasis.
Lin Z, Liu Y, Cai S, Yang C, Zhou L, Li W. Lin Z, et al. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211039131. doi: 10.1177/15330338211039131. Technol Cancer Res Treat. 2021. PMID: 34669528 Free PMC article. - Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer.
Williams DS, Mouradov D, Browne C, Palmieri M, Elliott MJ, Nightingale R, Fang CG, Li R, Mariadason JM, Faragher I, Jones IT, Churilov L, Tebbutt NC, Gibbs P, Sieber OM. Williams DS, et al. Mod Pathol. 2020 Mar;33(3):483-495. doi: 10.1038/s41379-019-0353-2. Epub 2019 Aug 30. Mod Pathol. 2020. PMID: 31471586 - Pathophysiology and classification of pseudomyxoma peritonei.
Bignell M, Carr NJ, Mohamed F. Bignell M, et al. Pleura Peritoneum. 2016 Mar 1;1(1):3-13. doi: 10.1515/pp-2016-0008. Epub 2016 Apr 12. Pleura Peritoneum. 2016. PMID: 30911604 Free PMC article. Review. - Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis.
Kwak MS, Cha JM, Yoon JY, Jeon JW, Shin HP, Chang HJ, Kim HK, Joo KR, Lee JI. Kwak MS, et al. Medicine (Baltimore). 2017 Sep;96(35):e7882. doi: 10.1097/MD.0000000000007882. Medicine (Baltimore). 2017. PMID: 28858102 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous